53.65 USD
-0.18 (-0.33%)
53.8846 USD
+0.23 (+0.44%)
Overall MDLZ gets a fundamental rating of 5 out of 10. We evaluated MDLZ against 87 industry peers in the Food Products industry. While MDLZ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDLZ is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
MDLZ had a positive operating cash flow in the past year.
Each year in the past 5 years MDLZ has been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 4.95%, MDLZ is doing good in the industry, outperforming 75.86% of the companies in the same industry.
MDLZ has a better Return On Equity (13.49%) than 83.91% of its industry peers.
MDLZ has a better Return On Invested Capital (6.25%) than 68.97% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MDLZ is significantly below the industry average of 28.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
MDLZ has a better Profit Margin (9.38%) than 87.36% of its industry peers.
MDLZ's Profit Margin has declined in the last couple of years.
MDLZ has a Operating Margin of 11.59%. This is amongst the best in the industry. MDLZ outperforms 80.46% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 31.05%, MDLZ is doing good in the industry, outperforming 71.26% of the companies in the same industry.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
MDLZ has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MDLZ has been reduced compared to a year ago.
2.2 Solvency
MDLZ has an Altman-Z score of 2.22. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score of 2.22. This is comparable to the rest of the industry: MDLZ outperforms 49.43% of its industry peers.
The Debt to FCF ratio of MDLZ is 9.31, which is on the high side as it means it would take MDLZ, 9.31 years of fcf income to pay off all of its debts.
MDLZ has a Debt to FCF ratio of 9.31. This is in the better half of the industry: MDLZ outperforms 63.22% of its industry peers.
MDLZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.76, MDLZ is in line with its industry, outperforming 41.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.22 |
ROIC/WACC0.84
WACC7.44%
2.3 Liquidity
A Current Ratio of 0.61 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a worse Current ratio (0.61) than 87.36% of its industry peers.
A Quick Ratio of 0.37 indicates that MDLZ may have some problems paying its short term obligations.
With a Quick ratio value of 0.37, MDLZ is not doing good in the industry: 81.61% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased strongly by -21.70% in the last year.
The Earnings Per Share has been growing slightly by 6.91% on average over the past years.
Looking at the last year, MDLZ shows a small growth in Revenue. The Revenue has grown by 4.13% in the last year.
The Revenue has been growing slightly by 7.09% on average over the past years.
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
The Earnings Per Share is expected to grow by 3.92% on average over the next years.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.82 indicates a rather expensive valuation of MDLZ.
MDLZ's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of MDLZ to the average of the S&P500 Index (26.60), we can say MDLZ is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 16.73, the valuation of MDLZ can be described as correct.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 65.52% of the companies in the same industry.
MDLZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.23.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.82 | ||
| Fwd PE | 16.73 |
4.2 Price Multiples
MDLZ's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.23 | ||
| EV/EBITDA | 15.18 |
4.3 Compensation for Growth
MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.72
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 3.72%.
Compared to an average industry Dividend Yield of 2.41, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, MDLZ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
5.2 History
On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
69.92% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
53.65
-0.18 (-0.33%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners89.35%
Inst Owner Change0%
Ins Owners0.15%
Ins Owner Change0%
Market Cap69.23B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts78.24
Price Target69.55 (29.64%)
Short Float %2.46%
Short Ratio3.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-0.81%
PT rev (3m)-7.31%
EPS NQ rev (1m)-0.42%
EPS NQ rev (3m)-14.92%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-4.16%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.56%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.82 | ||
| Fwd PE | 16.73 | ||
| P/S | 1.84 | ||
| P/FCF | 30.23 | ||
| P/OCF | 19.36 | ||
| P/B | 2.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.18 |
EPS(TTM)2.85
EY5.31%
EPS(NY)3.21
Fwd EY5.98%
FCF(TTM)1.77
FCFY3.31%
OCF(TTM)2.77
OCFY5.17%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.72
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.22 |
F-Score5
WACC7.44%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year6.67%
EBIT Next 3Y6.61%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 5 / 10 to MDLZ.
Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for MDLZ stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 18.82 and the Price/Book (PB) ratio is 2.64.
Can you provide the dividend sustainability for MDLZ stock?
The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 69.92%.